# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-22-013882
Filing Date
2022-04-07
Accepted
2022-04-07 17:15:17
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | pstv-defa14a_20220407.htm | DEFA14A | 15130
2 | GRAPHIC | glwwrtf2k3b5000001.jpg | GRAPHIC | 768834
3 | GRAPHIC | glwwrtf2k3b5000002.jpg | GRAPHIC | 470905
| Complete submission text file | 0001564590-22-013882.txt |  | 1723778

Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34375 | Film No.: 22814642
SIC: 3841 Surgical & Medical Instruments & Apparatus